Schedule 13D ownership disclosure

GoodRx Holdings Inc

Class A Common Stock · CUSIP: 38246G108

Event date: 2025-07-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Spectrum Equity VII, L.P.Reported CIK 0001609969

    Shares: 14,865,346 · Class: 12.9%

  • Spectrum Equity Associates VII, L.P.Reported CIK 0001824228

    Shares: 14,865,346 · Class: 12.9%

  • Spectrum VII Investment Managers' Fund, L.P.Reported CIK 0001626997

    Shares: 25,445 · Class: 0.02%

  • Spectrum VII Co-Investment Fund, L.P.Reported CIK 0001822087

    Shares: 14,342 · Class: 0.01%

  • SEA VII Management, LLCReported CIK 0001824265

    Shares: 14,905,133 · Class: 12.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-094107
Form type
SCHEDULE 13D/A
Filer
GoodRx Holdings, Inc.
CIK
CIK 1809519
Filed
Jul 03, 2025
Reporting period
Jul 02, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub